Form 4: Centessa Pharmaceuticals Executive Reports Share Disposal for Tax Obligations
SEC Form 4 Filing
Tia L. Bush, Chief Technology & Quality Officer of Centessa Pharmaceuticals, disposed of 6,419 ordinary shares to cover tax withholding obligations related to vesting restricted share units.
Summary
- On June 30, 2024, Tia L. Bush, Chief Technology & Quality Officer of Centessa Pharmaceuticals plc, disposed of 6,419 ordinary shares.
- The transaction was executed to cover tax withholding obligations associated with the vesting of restricted share units.
- The shares were disposed of at a price of $9.03 per share.
- Following the transaction, Bush directly owns 163,645 ordinary shares of Centessa Pharmaceuticals plc.
Sentiment
Score: 6
Explanation: The sentiment is neutral as the filing reflects a routine transaction for tax purposes, not necessarily indicative of the executive's outlook on the company's future performance.
Industry Context
Form 4 filings are standard practice and provide transparency into the transactions of company insiders, allowing investors to track executive sentiment and potential alignment with company performance.
Stakeholder Impact
- The transaction has a minimal impact on shareholders as it is a standard procedure for covering tax obligations.
Key Dates
| Date | Description |
|---|---|
| 06/30/2024 | Date of the share disposal transaction. |
| 07/02/2024 | Date of signature for the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.